Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGFRL1 | Q5TC84 | 20/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 18/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 18/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 13/20 | 1.00 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL853438 | 1.00 | OGFRL1 (1.00) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL853439 | 1.00 | OGFRL1 (1.00) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL852438 | 0.89 | OGFRL1 (1.00) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL852439 | 0.89 | OGFRL1 (1.00) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL852420 | 0.88 | OGFRL1 (0.79) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL852421 | 0.88 | OGFRL1 (0.79) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL21547953 | 0.88 | OGFRL1 (0.78) | OGFRL1OPRM1OPRK1OPRD1 | |
| SCHEMBL853065 | 0.88 | OGFRL1 (0.78) | OGFRL1OPRM1OPRK1OPRD1 | |
| SCHEMBL853064 | 0.88 | OGFRL1 (0.78) | OGFRL1OPRM1OPRK1OPRD1 | |
| SCHEMBL21548057 | 0.87 | OGFRL1 (1.00) | OGFRL1OPRM1OPRK1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2880033-B1 | CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA LP (US) | 2020-06-17 | — | — | EP | disclosed |
| EP-3564240-A1 | PIPERIDINE INTERMEDIATES | Purdue Pharma L.P. (US) | 2019-11-06 | — | — | EP | disclosed |